
Merck's Covid-19 pill is great news but may not be a game-changer
CNN
A new approach to managing the Covid-19 pandemic now could be on the table: antiviral pills. On Friday, Merck and Ridgeback Biotherapeutics said their results (still not peer-reviewed) demonstrate their novel drug molnupiravir cut in half the rate of hospitalization and death in persons with mild to moderate disease. If authorized by the US Food and Drug Administration for emergency use, the pill would become the first oral medicine to fight viral infection for Covid-19.

More photos from Epstein’s estate released by House Democrats as deadline to release DOJ files looms
Democrats on the House Oversight Committee released photos from Jeffrey Epstein’s estate Thursday — the latest in a series of intermittent disclosures that have fueled significant political intrigue in recent weeks about who may have been associated with the convicted sex offender.












